Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.

Li J, Hu ZE, Yang XL, Wu WX, Xing X, Gu B, Liu YH, Wang N, Yu XQ.

Biomater Sci. 2019 Jun 10. doi: 10.1039/c9bm00425d. [Epub ahead of print]

PMID:
31180396
2.

Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.

Dong S, Sun Y, Liu J, Li L, He J, Zhang M, Ni P.

ACS Appl Mater Interfaces. 2019 Mar 6;11(9):8740-8748. doi: 10.1021/acsami.8b16363. Epub 2019 Feb 20.

PMID:
30693750
3.

Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.

Li Y, Yang H, Yao J, Yu H, Chen X, Zhang P, Xiao C.

Colloids Surf B Biointerfaces. 2018 Sep 1;169:273-279. doi: 10.1016/j.colsurfb.2018.05.025. Epub 2018 May 17.

PMID:
29787951
4.

Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.

Jin H, Sun M, Shi L, Zhu X, Huang W, Yan D.

Biomater Sci. 2018 May 29;6(6):1403-1413. doi: 10.1039/c8bm00162f.

PMID:
29595843
5.

mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.

Qin B, Liu L, Wu X, Liang F, Hou T, Pan Y, Song S.

Acta Biomater. 2017 Dec;64:211-222. doi: 10.1016/j.actbio.2017.09.040. Epub 2017 Sep 27.

PMID:
28963017
6.

Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.

Xu Z, Wang D, Xu S, Liu X, Zhang X, Zhang H.

Chem Asian J. 2014 Jan;9(1):199-205. doi: 10.1002/asia.201301030. Epub 2013 Oct 17.

PMID:
24136878
7.

Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.

Yin T, Wang Y, Chu X, Fu Y, Wang L, Zhou J, Tang X, Liu J, Huo M.

ACS Appl Mater Interfaces. 2018 Oct 24;10(42):35693-35704. doi: 10.1021/acsami.8b09342. Epub 2018 Oct 11.

PMID:
30259743
8.

Dual Stimuli-Responsive Polymer Prodrugs Quantitatively Loaded by Nanoparticles for Enhanced Cellular Internalization and Triggered Drug Release.

Huang M, Zhao K, Wang L, Lin S, Li J, Chen J, Zhao C, Ge Z.

ACS Appl Mater Interfaces. 2016 May 11;8(18):11226-36. doi: 10.1021/acsami.5b12227. Epub 2016 Apr 29.

PMID:
27100328
9.

Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.

Sun JJ, Chen YC, Huang YX, Zhao WC, Liu YH, Venkataramanan R, Lu BF, Li S.

Acta Pharmacol Sin. 2017 Jun;38(6):823-834. doi: 10.1038/aps.2017.44. Epub 2017 May 8.

10.

Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.

Xu Z, Liu S, Kang Y, Wang M.

Nanoscale. 2015 Mar 19;7(13):5859-68. doi: 10.1039/c5nr00297d.

PMID:
25757484
11.

In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.

Li WM, Su CW, Chen YW, Chen SY.

Acta Biomater. 2015 Mar;15:191-9. doi: 10.1016/j.actbio.2014.12.013. Epub 2014 Dec 24.

PMID:
25542535
12.

Camptothecin prodrug nanomicelle based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.

Gao Y, Xiao Y, Liu S, Yu J.

J Biomater Sci Polym Ed. 2018 Feb;29(2):160-180. doi: 10.1080/09205063.2017.1406632. Epub 2017 Nov 21.

PMID:
29145770
13.

Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.

Wang L, Tian B, Zhang J, Li K, Liang Y, Sun Y, Ding Y, Han J.

Int J Pharm. 2016 Mar 30;501(1-2):221-35. doi: 10.1016/j.ijpharm.2016.02.002. Epub 2016 Feb 3.

PMID:
26851356
14.

Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.

Sun J, Liu Y, Chen Y, Zhao W, Zhai Q, Rathod S, Huang Y, Tang S, Kwon YT, Fernandez C, Venkataramanan R, Li S.

J Control Release. 2017 Jul 28;258:43-55. doi: 10.1016/j.jconrel.2017.05.006. Epub 2017 May 12.

15.

Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.

Xu M, Qian J, Liu X, Liu T, Wang H.

Mater Sci Eng C Mater Biol Appl. 2015 May;50:341-7. doi: 10.1016/j.msec.2015.01.098. Epub 2015 Jan 31.

PMID:
25746279
16.

Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.

Gao D, Lo PC.

J Control Release. 2018 Jul 28;282:46-61. doi: 10.1016/j.jconrel.2018.04.030. Epub 2018 Apr 16.

PMID:
29673646
17.

Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin.

Wu Y, Zhou D, Zhang Q, Xie Z, Chen X, Jing X, Huang Y.

Biomacromolecules. 2016 Aug 8;17(8):2650-61. doi: 10.1021/acs.biomac.6b00705. Epub 2016 Jul 13.

PMID:
27384255
18.

Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.

Shen Y, Jin E, Zhang B, Murphy CJ, Sui M, Zhao J, Wang J, Tang J, Fan M, Van Kirk E, Murdoch WJ.

J Am Chem Soc. 2010 Mar 31;132(12):4259-65. doi: 10.1021/ja909475m.

PMID:
20218672
19.

Cisplatin-Stitched Polysaccharide Vesicles for Synergistic Cancer Therapy of Triple Antagonistic Drugs.

Deshpande NU, Jayakannan M.

Biomacromolecules. 2017 Jan 9;18(1):113-126. doi: 10.1021/acs.biomac.6b01411. Epub 2016 Dec 8.

PMID:
28064505
20.

pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.

Lin W, Yao N, Qian L, Zhang X, Chen Q, Wang J, Zhang L.

Acta Biomater. 2017 Aug;58:455-465. doi: 10.1016/j.actbio.2017.06.003. Epub 2017 Jun 3.

PMID:
28583900

Supplemental Content

Support Center